KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $325 | +104.4% | 10,887 | +175.4% | 0.00% | +100.0% |
| Q1 2024 | $159 | -66.4% | 3,953 | -78.7% | 0.00% | -75.0% |
| Q4 2023 | $473 | +81.9% | 18,563 | +111.6% | 0.00% | +33.3% |
| Q1 2023 | $260 | -99.9% | 8,772 | +1.7% | 0.00% | +50.0% |
| Q3 2022 | $188,000 | -74.4% | 8,629 | -76.9% | 0.00% | -75.0% |
| Q2 2022 | $735,000 | +146.6% | 37,345 | +430.2% | 0.01% | +300.0% |
| Q1 2022 | $298,000 | -55.6% | 7,044 | -33.4% | 0.00% | -50.0% |
| Q4 2021 | $671,000 | -32.4% | 10,576 | -37.4% | 0.00% | -20.0% |
| Q3 2021 | $993,000 | +480.7% | 16,903 | +379.9% | 0.01% | +400.0% |
| Q2 2021 | $171,000 | +9.6% | 3,522 | -12.2% | 0.00% | 0.0% |
| Q1 2021 | $156,000 | – | 4,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,350,422 | $159,710,097 | 16.82% |
| Aquilo Capital Management, LLC | 328,743 | $9,812,979 | 9.46% |
| BVF INC/IL | 5,161,801 | $154,079,760 | 4.32% |
| Redmile Group, LLC | 1,579,275 | $47,141,359 | 2.85% |
| Deer Management Co. LLC | 415,895 | $12,414,466 | 2.55% |
| Artal Group S.A. | 3,005,610 | $89,717,459 | 2.29% |
| Baker Brothers Advisors | 5,995,928 | $178,978,451 | 2.29% |
| Avoro Capital Advisors LLC | 3,888,888 | $116,083,307 | 1.55% |
| Checkpoint Capital L.P. | 82,000 | $2,447,700 | 1.48% |
| Deep Track Capital, LP | 1,500,000 | $44,775,000 | 1.34% |